Chiral Alkyl Halides: Underexplored Motifs in Medicine

Marine Drugs - Tập 14 Số 11 - Trang 206
Bálint Gál1, Cyril Bucher1, Noah Z. Burns1
1Department of Chemistry, Stanford University, 333 Campus Drive, Stanford, CA 94305, USA

Tóm tắt

While alkyl halides are valuable intermediates in synthetic organic chemistry, their use as bioactive motifs in drug discovery and medicinal chemistry is rare in comparison. This is likely attributable to the common misconception that these compounds are merely non-specific alkylators in biological systems. A number of chlorinated compounds in the pharmaceutical and food industries, as well as a growing number of halogenated marine natural products showing unique bioactivity, illustrate the role that chiral alkyl halides can play in drug discovery. Through a series of case studies, we demonstrate in this review that these motifs can indeed be stable under physiological conditions, and that halogenation can enhance bioactivity through both steric and electronic effects. Our hope is that, by placing such compounds in the minds of the chemical community, they may gain more traction in drug discovery and inspire more synthetic chemists to develop methods for selective halogenation.

Từ khóa


Tài liệu tham khảo

Carey, F.A., and Sundberg, R.J. (2007). Advanced Organic Chemistry, Part B: Reaction and Synthesis, Springer. [5th ed.].

Kambe, 2011, Pd-catalyzed cross-coupling reactions of alkyl halides, Chem. Soc. Rev., 40, 4937, 10.1039/c1cs15129k

Nicolaou, 2006, Cascade Reactions in Total Synthesis, Angew. Chem. Int. Ed., 45, 7134, 10.1002/anie.200601872

Los, 2008, HaloTag: A Novel Protein Labeling Technology for Cell Imaging and Protein Analysis, ACS Chem. Biol., 3, 373, 10.1021/cb800025k

Frang, 2001, Phenoxybenzamine Binding Reveals the Helical Orientation of the Third Transmembrane Domain of Adrenergic Receptors, J. Biol. Chem., 276, 31279, 10.1074/jbc.M104167200

WHO Model List of Essential Medicines. Available online: http://www.who.int/medicines/publications/essentialmedicines/en/index.html.

Smith, 1999, Pharmacokinetics and metabolism in early drug discovery, Curr. Opin. Chem. Biol., 3, 373, 10.1016/S1367-5931(99)80056-8

Gerebtzoff, 2004, Halogenation of Drugs Enhances Membrane Binding and Permeation, ChemBioChem, 5, 676, 10.1002/cbic.200400017

Gentry, 1999, The effect of halogenation on blood-brain barrier permeability of a novel peptide drug, Peptides, 20, 1229, 10.1016/S0196-9781(99)00127-8

Xu, 2014, Halogen Bond: Its Role beyond Drug-Target Binding Affinity for Drug Discovery and Development, J. Chem. Inf. Model., 54, 69, 10.1021/ci400539q

Gillis, 2015, Applications of Fluorine in Medicinal Chemistry, J. Med. Chem., 58, 8315, 10.1021/acs.jmedchem.5b00258

Franks, 2008, General Anaesthesia: From Molecular Targets to Neural Pathways of Sleep and Arousal, Nat. Rev. Neurosci., 9, 370, 10.1038/nrn2372

Franks, 1991, Stereospecific Effects of Inhalational General Anesthetic Optical Isomers on Nerve Ion Channels, Science, 254, 427, 10.1126/science.1925602

Liu, 2005, Structural Bases for High-Affinity Volatile Anesthetic Binding in a Natural 4-Helix Bundle Protein, FASEB J., 19, 567, 10.1096/fj.04-3171com

Cavallo, 2016, The halogen bond, Chem. Rev., 116, 2478, 10.1021/acs.chemrev.5b00484

Parisini, 2011, Halogen bonding in halocarbon-protein complexes: A structural survey, Chem. Soc. Rev., 40, 2267, 10.1039/c0cs00177e

Clindamycin Hydrochloride. Available online: https://www.drugs.com/monograph/clindamycin-hydrochloride.html.

Gale, E.F., Cundliffe, E., Reynolds, P.E., Richmond, M.H., and Waring, M.J. (1981). The Molecular Basis of Antibiotic Action, John Wiley & Sons. [2nd ed.].

1985, Structure Activity Relationships in Lincosamide and Streptogramin Antibiotics, J. Antimicrob. Chemother., 16, 13, 10.1093/jac/16.suppl_A.13

Douthwaite, 1992, Interaction of the Antibiotics Clindamycin and Lincomycin with Escherichia coli 23S Ribosomal RNA, Nucleic Acids Res., 20, 4717, 10.1093/nar/20.18.4717

Zarivach, 2001, Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria, Nature, 413, 814, 10.1038/35101544

Barnes, 1999, Therapeutic strategies for allergic diseases, Nature, 402, B31, 10.1038/35037026

Kumar, 1999, The structure of the nuclear hormone receptors, Steroids, 64, 310, 10.1016/S0039-128X(99)00014-8

Kohn, 2012, Deciphering modern glucocorticoid cross-pharmacology using ancestral corticosteroid receptors, J. Biol. Chem., 287, 16267, 10.1074/jbc.M112.346411

Wolff, 1978, Nature of steroid-glucocorticoid receptor interactions: Thermodynamic analysis of the binding reaction, Biochemistry, 17, 3201, 10.1021/bi00609a005

Buchwald, 2008, Glucocorticoid receptor binding: A biphasic dependence on molecular size as revealed by the bilinear LinBiExp mode, Steroids, 73, 193, 10.1016/j.steroids.2007.10.001

Allen, 2003, Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients, Arch. Dis. Child., 88, 969, 10.1136/adc.88.11.969

Weiss, 2008, Binding of Pimecrolimus and Tacrolimus to Skin and Plasma Proteins: Implications for Systemic Exposure after Topical Application, Drug Metab. Dispos., 336, 1812, 10.1124/dmd.108.021915

Knight, 1994, The development and applications of sucralose, a new high-intensity sweetener, Can. J. Physiol. Pharmacol., 72, 435, 10.1139/y94-063

Roberts, 2000, Sucralose metabolism and pharmacokinetics in man, Food Chem. Toxicol., 38, S31, 10.1016/S0278-6915(00)00026-0

Schallenberger, 1967, Molecular theory of sweet taste, Nature, 216, 480, 10.1038/216480a0

Schallenberger, 1969, Molecular structure and sweet taste, J. Acric. Food Chem., 17, 701, 10.1021/jf60164a032

Kier, 1972, Molecular theory of sweet taste, J. Pharm. Sci., 61, 1394, 10.1002/jps.2600610910

Newman, 2016, Natural Products as Sources of New Drugs from 1981 to 2014, J. Nat. Prod., 79, 629, 10.1021/acs.jnatprod.5b01055

Gribble, 2015, Biological Activity of Recently Discovered Halogenated Marine Natural Products, Mar. Drugs, 13, 4044, 10.3390/md13074044

Burreson, 1975, Evidence for the biogenesis of halogenated myrcenes from the red alga Chondrococcus hornemanni, Chem. Lett., 4, 1111, 10.1246/cl.1975.1111

Fuller, 1992, A pentahalogenated monoterpene from the red alga Portieria hornemannii produces a novel cytotoxicity profile against a diverse panel of human tumor cell lines, J. Med. Chem., 35, 3007, 10.1021/jm00094a012

Fuller, 1994, Isolation and Structure/Activity Features of Halomon-Related Antitumor Monoterpenes from the Red Alga Portieria hornemannii, J. Med. Chem., 37, 4407, 10.1021/jm00051a019

Andrianasolo, 2006, DNA Methyl Transferase Inhibiting Halogenated Monoterpenes from the Madagascar Red Marine Alga Portieria hornemannii, J. Nat. Prod., 69, 576, 10.1021/np0503956

Paull, 1989, Display and analysis of patterns of differential activity of drugs against human tumor cell lines: Development of mean graph and COMPARE algorithm, J. Natl. Cancer Inst., 81, 1088, 10.1093/jnci/81.14.1088

Bucher, 2015, Highly Selective Synthesis of Halomon, Plocamenone, and Isoplocamenone, J. Am. Chem. Soc., 137, 12784, 10.1021/jacs.5b08398

Bucher, C., Valeriote, F.A., and Burns, N.Z. (2016). Unpublished work.

Guiraud, 1994, Comparison of Antibacterial and Antifungal Activities of Lapachol and β-Lapachone, Planta Med., 60, 373, 10.1055/s-2006-959504

Ravelo, 2005, Antiplasmodial Activity of Naphthoquinones Related to Lapachol and β-Lapachone, Chem. Biodivers., 2, 264, 10.1002/cbdv.200590009

Goulart, 2004, Antimalarial activity of phenazines from lapachol, β-lapachone and its derivatives against Plasmodium falciparum in vitro and Plasmodium berghei in vivo, Bioorg. Med. Chem. Lett., 14, 1145, 10.1016/j.bmcl.2003.12.069

Pardee, 2002, Cancer therapy with β-lapachone, Curr. Cancer Drug Targets, 2, 224, 10.2174/1568009023333854

Ravelo, 2007, Synthesis and pharmacophore modeling of naphthoquinone derivatives with cytotoxic activity in human promyelocytic leukemia HL-60 cell line, J. Med. Chem., 50, 696, 10.1021/jm060849b

Morita, 1996, Cyclic peptides from higher plants. XXVIII. Antitumor activity and hepatic microsomal biotransformation of cyclic pentapeptides, astins, from Aster tataricus, Chem. Pharm. Bull., 5, 1026, 10.1248/cpb.44.1026

Wyche, 2014, Forazoline A: marine-derived polyketide with antifungal in vivo efficacy, Angew. Chem. Int. Ed. Engl., 53, 11583, 10.1002/anie.201405990

Thông tin
Thông tin xuất bản

Marine Drugs

Tập 14 Số 11

206

Thông tin tác giả